New £33m unit will be built at Rhyl's Royal Alexandra Hospital.

A new £33m healthcare unit at Rhyl's Royal Alexandra Hospital will include a minor injuries service, expanded radiology and a 14-bed reablement unit, and is due to be completed next year.

A new £33m healthcare unit will be built at the Royal Alexandra Hospital in Rhyl as part of efforts to improve NHS services in north Wales. The development will include a minor injuries unit and a 14‑bed "ready‑to‑go‑home" reablement unit. It is reported the facility could treat more than 20,000 people a year and will expand radiology services and add four new dental suites. The project is described as the first phase of a wider £60m investment and is due to be completed next year. Key details: - The new unit is budgeted at £33m and will include a minor injuries service and expanded diagnostic and dental facilities. - The reablement unit has 14 beds and is intended to bring NHS and social care teams together to support people returning home after treatment. - The development is expected to treat more than 20,000 people a year and will add four dental suites with more training opportunities for dental nurses. - This work is the first phase of a planned £60m investment; a business case for phase two is expected to be submitted by Betsi Cadwaladr University Health Board. - Plans for a new hospital on the Royal Alexandra site were first approved in 2013; by 2018 costs had risen and the original plans were halted during the Covid‑19 pandemic, and the health board said the earlier proposal was no longer affordable. Summary: Officials say the new unit should help expand local capacity, increase diagnostics and dental services, and ease pressure on nearby emergency services. The construction is due to finish next year and the health board plans to submit a business case for the second phase. Some local politicians described the announcement as delayed and reduced in scale after earlier plans dating back to 2013. What follows next is the completion of phase one and consideration of the phase two business case.